Cerebrospinal fluid characteristics of patients treated with intrathecal nusinersen for spinal muscular atrophy.

Authors:
Orbach R; Sagi L; Sadot E; Tokatly Latzer I; Shtamler A and 2 more

Journal:
Muscle Nerve

Publication Year: 2022

DOI:
10.1002/mus.27731

PMCID:
PMC9828332

PMID:
36214191

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Muscle Nerve

Abbreviation: Muscle Nerve

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Physiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Assessment timing and choice of outcome measure in determining treatment response in chronic inflam…
Rajabally YA; Ouaja R; Kasiborski F and 2 more (2022) - Transparency Score: 3/6
Association of diaphragm thickness and echogenicity with age, sex, and body mass index in healthy s…
van Doorn JLM; Wijntjes J; Saris CGJ and 3 more (2022) - Transparency Score: 2/6
Body composition and myokines in a cohort of patients with Becker muscular dystrophy.
Barp A; Carraro E; Goggi G and 8 more (2022) - Transparency Score: 3/6
Cardiac and pulmonary findings in dysferlinopathy: A 3-year, longitudinal study.
Moore U; Fernandez-Torron R; Jacobs M and 28 more (2022) - Transparency Score: 3/6
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammator…
Gil-Vila A; Ravichandran N; Selva-O'Callaghan A and 32 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST None of the authors has any conflict of interest to disclose."

Evidence found in paper:

"FUNDING INFORMATION This research did not receive any specific grant from funding agencies in the public, commercial, or not‐for‐profit sectors."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025